These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26106125)

  • 1. Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.
    Feichtinger RG; Weis S; Mayr JA; Zimmermann FA; Bogner B; Sperl W; Kofler B
    Neuro Oncol; 2016 Feb; 18(2):184-94. PubMed ID: 26106125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of oxidative phosphorylation complexes in astrocytomas.
    Feichtinger RG; Weis S; Mayr JA; Zimmermann F; Geilberger R; Sperl W; Kofler B
    Glia; 2014 Apr; 62(4):514-25. PubMed ID: 24446254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
    Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
    APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
    Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
    Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
    Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
    Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.
    Trott G; Pereira-Lima JF; Leães CG; Ferreira NP; Barbosa-Coutinho LM; Oliveira MC
    Braz J Med Biol Res; 2015 May; 48(5):415-9. PubMed ID: 25742638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression.
    Ke HL; Ke RH; Li ST; Li B; Lu HT; Wang XQ
    J Neurooncol; 2013 Jun; 113(2):327-32. PubMed ID: 23525949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation markers of malignant potential in meningiomas.
    Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
    J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
    Katz LM; Hielscher T; Liechty B; Silverman J; Zagzag D; Sen R; Wu P; Golfinos JG; Reuss D; Neidert MC; Wirsching HG; Baumgarten P; Herold-Mende C; Wick W; Harter PN; Weller M; von Deimling A; Snuderl M; Sen C; Sahm F
    Acta Neuropathol; 2018 Jun; 135(6):955-963. PubMed ID: 29627952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker.
    Parada CA; Osbun JW; Busald T; Karasozen Y; Kaur S; Shi M; Barber J; Adidharma W; Cimino PJ; Pan C; Gonzalez-Cuyar LF; Rostomily R; Born DE; Zhang J; Ferreira M
    Clin Cancer Res; 2020 Jan; 26(1):193-205. PubMed ID: 31615938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of MRP5 expression in meningiomas.
    Alexiou GA; Goussia A; Ntoulia A; Zagorianakou P; Malamou-Mitsi V; Voulgaris S; Kyritsis AP
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):825-8. PubMed ID: 23271324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
    Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ
    Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
    Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
    J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
    Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
    Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of p63 protein expression with histological grade of meningiomas: an immunohistochemical study.
    Mittal S; Jain D; Roy S; Mehta VS
    Int J Surg Pathol; 2012 Aug; 20(4):349-54. PubMed ID: 22287651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.